133 related articles for article (PubMed ID: 27390311)
1. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
Koizumi H; Kawaguchi R; Ohkubo JI; Ikezaki S; Kitamura T; Hohchi N; Hashida K; Suzuki H
Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
[TBL] [Abstract][Full Text] [Related]
2. Expressions of TRPVs in the cholesteatoma epithelium.
Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
[TBL] [Abstract][Full Text] [Related]
3. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
4. Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use.
Cheong KA; Lee TR; Lee AY
J Dermatol Sci; 2017 Aug; 87(2):192-200. PubMed ID: 28433430
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
[TBL] [Abstract][Full Text] [Related]
6. Increased permeability of the epithelium of middle ear cholesteatoma.
Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
[TBL] [Abstract][Full Text] [Related]
7. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
[TBL] [Abstract][Full Text] [Related]
8. Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
Chang CS; Jun BH; Song KY; Kim IG
J Korean Med Sci; 1999 Dec; 14(6):665-70. PubMed ID: 10642946
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis.
Simon M; Tazi-Ahnini R; Jonca N; Caubet C; Cork MJ; Serre G
Br J Dermatol; 2008 Jul; 159(1):77-85. PubMed ID: 18460028
[TBL] [Abstract][Full Text] [Related]
10. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
[TBL] [Abstract][Full Text] [Related]
11. Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
McGovern JA; Meinert C; de Veer SJ; Hollier BG; Parker TJ; Upton Z
Br J Dermatol; 2017 Jan; 176(1):145-158. PubMed ID: 27442805
[TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
14. Expressions of caspase-14 in human middle ear cholesteatoma.
Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of placenta growth factor in human middle ear cholesteatoma.
Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
[TBL] [Abstract][Full Text] [Related]
16. [Epidermal growth factor in cholesteatoma--the second report: the localization in the horny layer].
Goto Y
Nihon Jibiinkoka Gakkai Kaiho; 1990 Aug; 93(8):1192-9. PubMed ID: 2231169
[TBL] [Abstract][Full Text] [Related]
17. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
19. Alteration of epidermal differentiation in middle ear cholesteatoma.
Stammberger M; Bujía J; Kastenbauer E
Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
[TBL] [Abstract][Full Text] [Related]
20. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
